International Journal of Pharmaceutical Investigation logo

International Journal of Pharmaceutical Investigation

Table of Contents

Pick an issue to see its articles, then open an article for its abstract, keywords, references and PDF.

International Journal of Pharmaceutical Investigation

Volume 16, Issue 4

2026 · pp. 1202–1724 · 50 articles

Volume
16
Issue
4
Published
2026
Pages
1202–1724
Articles
50
Sections
2
ISSN
2230-9713
Journal
IJPI

In this issue

41–50 of 50

Original Article(continued)

  1. Magesh Mohan, Renukadevi Jeyavelkumaran, Sanjay Valliappan, Shakthi Harikrishnan, Kadir Aravindan, Balaji Ravikuma

    pp. 1601-1621 · DOI: 10.5530/ijpi.20260291 · 2026

    Background: Breast cancer progression is governed by highly interconnected signaling networks involving receptor tyrosine kinases and hormone-responsive nuclear receptors, which collectively drive tumor heterogeneity, ad…

  2. Md. Zeyaullah, Kamal Ahmad

    pp. 1622-1628 · DOI: 10.5530/ijpi.20260014 · 2026

    Background: This study evaluates COVID-19 vaccination coverage, vaccine effectiveness against SARS-CoV-2 variants, and associated health consequences in the five most important Indian metropolitan cities: Delhi, Mumbai, …

  3. Krutika Lolsure, Vijay Kumbar, Priya Shetti, Mitali Kubade, Malleswara Peram

    pp. 1629-1634 · DOI: 10.5530/ijpi.20260016 · 2026

    Introduction: Glioblastoma multiforme, an extremely aggressive form of brain cancer, presents significant challenges in treatment, despite the application of surgical intervention, radiation therapy, and chemotherapy. Re…

  4. Sruthi Sai Kaveripakam, Sreedevi Adikay, Sowmya Venkata Donthamsetty, Surekha Lakshmi Khandavilli

    pp. 1635-1641 · DOI: 10.5530/ijpi.20260025 · 2026

    Background: Phytochemicals exhibit diverse therapeutic properties with minimal adverse effects and documented their benefits against metabolic disorders. Inhibition of pancreatic lipase is a validated strategy for managi…

  5. Tahani Bakhsh

    pp. 1642-1656 · DOI: 10.5530/ijpi.20260058 · 2026

    Background: MDM2 is an E3 ubiquitin ligase that suppresses p53, promotes its degradation, inhibits apoptosis, and drives uncontrolled cancer cell growth. Targeting the MDM2-p53 interaction is therefore a promising strate…

  6. K. K Mueen Ahmed, M Chaman Sab, Mohammed Yunus, Shery Jacob, Jigar N. Shah, Hiral J. Shah, Mahesh Attimarad, Sreeharsha Nagaraja, Rashed M. Almuqbil, Bandar E. Al-Dhubiab, Katharigatta N. Venugopala, Abdullah M. Alotaibi, Ahmed S. Alnaim

    pp. 1657-1665 · DOI: 10.5530/ijpi.20260004 · 2026

    Objective: Drug delivery and pharmaceutical-analysis research spans a wide range of sub-disciplines - nanocarrier formulation, transdermal and iontophoretic delivery, analytical method development, and computational drug…

  7. Jahanvi Patel, Tejal Mehta

    pp. 1666-1679 · DOI: 10.5530/ijpi.20260292 · 2026

    Background: The primary objective of this study was to develop, optimize and evaluate a paediatric-friendly, pullulan-based Mouth Dissolving Film (MDF) of Ferrous Bisglycinate as a novel iron delivery system. The work ai…

  8. S. Revathy, K. Shoba, A. Vidhya

    pp. 1680-1695 · DOI: 10.5530/ijpi.20260024 · 2026

    Background: Trigonella foenum-graecum (fenugreek) is a widely utilized medicinal herb known for its therapeutic potential in managing metabolic disorders. This study aimed to extract and characterise the bioactive consti…

  9. Sanket Keshav Tambe, Rohit Jaysing Bhor, Sagar Dattatray Magar, Mayur Shivaji Bhosale, Shubham Popatrao Mankar, Datta Macchindra Abhale, Sachin Tukaram chavan, Gaurav Subhash Damre

    pp. 1696-1718 · DOI: 10.5530/ijpi.20260011 · 2026

    Background: This study focuses on the computational (in silico) analysis of 1H-phenothiazine derivatives to estimate their pharmacological potential, particularly as inhibitors of monoamine oxidase (PDB ID: 2BXR), an enz…

  10. Vishal Kulkarni, Kavya Mattikatti, Manasa Desai, Darshan Randewadi, Nida Sirdesai, Sanatkumar Bharamu Nyamagoud, AHM Viswanatha Swamy

    pp. 1719-1724 · DOI: 10.5530/ijpi.20260176 · 2026

    Aim: To evaluate early changes in symptom-specific Health-Related Quality of Life (HRQoL) among Esophageal cancer patients receiving chemotherapy up to the second cycle and to assess demographic and treatment-related dif…